Biggest News Aggregation in the World
📰 Security Administrations News

Security Administrations News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Security Administrations. Real-time updates on events, politics, business and more.

Brii Biosciences Announces Positive Data from a Randomized, Single-Blind Study of its Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China

Data are consistent with the results of the global Phase 3 ACTIV-2 trial, demonstrating a favorable safety and tolerability profile in people with both severe and non-severe SARS-CoV-2 infections in China Clinical benefits were observed in efficacy indicators such as RNAconversion rate, resolutionofCOVID-19 symptoms, and riskof progressing to severe disease DURHAM, N.C. and BEIJING, June 9, 2022 /PRNewswire/ --Brii Biosciences Limited("Brii Bio" or the "Company", stock code: ...
United States Nanshan Zhong Brii Bio Rogers Luo Therapeutics Beijing Co Ltd National Health Commission Of China

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science